Beckman Coulter s Biomedical Research Unit Grows 5 Percent in Market It Calls Sluggish | GenomeWeb

Led by its robotic automation and genetic analysis products, Beckman Coulter’s biomedical research division contributed 5 percent growth toward the company’s total revenues of $581 million for the quarter ending Sept. 30.

Beckman’s overall sales grew 8.7 percent for the period, compared to the same quarter in 2003, boosted by 10-percent growth in sales of $420 million for its clinical diagnostics unit.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.